Drug Profile
Teriparatide biosimilar - Elea
Alternative Names: Recombinant human parathyroid hormone 1-34 fraction - EleaLatest Information Update: 30 Oct 2021
Price :
$50
*
At a glance
- Originator Elea
- Class Diagnostic agents; Osteoporosis therapies; Peptide hormones; Skin disorder therapies
- Mechanism of Action Parathyroid hormone replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Osteoporosis